Spotlight on pharmaceuticals - A bitter pill

By Euan Hagger

Wednesday, September 29, 2010

A few years ago they had top ratings, but the creditworthiness of the world’s largest producers of branded pharmaceuticals is waning – and worse is to come.

Subscriber-only article

This article is available only to Creditflux subscribers and free trial users within 30 days of publication.

Already a subscriber? Not logged in? Click here to login.

If you have not already done so,
you may request a FREE TRIAL by clicking here

This trial will give you:
  • 4-weeks' free online access to our
    most recent subscriber-only articles
  • Daily breaking news alert sent by email
  • A print copy of Creditflux

If you currently have a free trial, you will see this message when you try to view articles older than 30 days.

Comment by: Anonymous. Posted 13 years ago [2010-10-06 00:24:20]

This article is well written, but I'm surprised it says nothing about US healthcare reform. This legislation will have a huge impact on the credit strength of the pharmaceutical companies.

Newsletter

more stories...